Search clinical trials for: LGMD2B/R2

Total 128 results

Sarepta Therapeutics, Inc.

Active, not recruiting

A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related)

Limb Girdle Muscular Dystrophy

United States
The R2 Institute

Unknown

Dietary Factors and Disfluency: A Look Into Food Allergies and Other Environmental Triggers Associated With Variations in Severity of Vocal Cord Tension.

Vocal Cord Tension | Dysfluency Developmental

United States
aTyr Pharma, Inc.

Completed

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (FSHD)

Limb-Girdle Muscular Dystrophies | Facioscapulohumeral Muscular Dystrophy

United States, Denmark, France
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 (Navipharm)

Healthy

Korea, Republic of
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

Healthy

Korea, Republic of
R2 Dermatology

Completed

Dermal Cooling System for Cryotherapy of Common Skin Conditions

Skin Lesion

United States
R2 Dermatology

Completed

Dermal Cryotherapy for Treatment of Pigmented Lesions

Pigmented Skin Lesion

United States, Canada
St. Jude Children's Research Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Regional...

Completed

Massive Iron Deposit Assessment

Iron Overload | Excessive Body Iron Burden

United States
University of Pennsylvania
Johns Hopkins University; Children's Hospital of Philadelphia; Boston Children...

Completed

Restore Resilience in Critically Ill Children (R2)

Acute Respiratory Distress Syndrome

United States
R2 Dermatology

Recruiting

Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions

Skin Lesion

United States
R2 Dermatology

Completed

Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions

Pigmentation

United States
R2 Dermatology

Completed

Dermal Cryotherapy in Patients Undergoing Abdominoplasty

Skin Laxity

United States
R2 Dermatology

Completed

Evaluation of a New Dermal Cryotherapy System

Skin Lightening

United States
Andrei Iagaru

Completed

Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | PSA Progression

United States
Daewon Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

Gastritis

Korea, Republic of
NVP Healthcare

Completed

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

Healthy

Korea, Republic of
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
NVP Healthcare

Recruiting

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

Cardiovascular Diseases

Korea, Republic of
Newcastle-upon-Tyne Hospitals NHS Trust
Jain Foundation

Active, not recruiting

Clinical Outcome Study for Dysferlinopathy (Jain COS)

Dysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi Myopathy

Korea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
Advanced Accelerator Applications

Completed

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (PROfind)

Prostate Cancer Metastatic

United States
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
NVP Healthcare

Completed

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 (NVP-1805)

Healthy

Korea, Republic of
Novartis Pharmaceuticals

Recruiting

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France
Masimo Corporation

Completed

Rainbow R2-25 vs. R1-25 SpHb Sub-Range Performance Equivalence

Healthy

United States
Advanced Accelerator Applications

Terminated

177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer (PROter)

Prostatic Neoplasm

United States, Spain
Lihir Medical Centre
World Health Organization; Harvard School of Public Health (HSPH); Barcelona... and other collaborators

Completed

Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication

Yaws

Papua New Guinea
Dong-A ST Co., Ltd.

Not yet recruiting

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Sarepta Therapeutics, Inc.

Completed

rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies

Dysferlinopathy

United States
Ruijin Hospital

Recruiting

Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

Follicular Lymphoma

China
SK Chemicals Co., Ltd.

Completed

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Healthy Subjects

Korea, Republic of
GE Healthcare

Completed

Vscan Access R2 Feasibility Evaluation

Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester

United States
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Healthy

Korea, Republic of
BioPheresis GmbH
Dr. M. Koehler GmbH; ARTIMED Medical Consulting GmbH

Terminated

Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities (BP-005)

Advanced Cancer Entities

Germany
Ruijin Hospital

Unknown

R2 in the Treatment of Follicular Lymphoma

Follicular Lymphoma

China
University Hospital, Clermont-Ferrand
France Parkinson Association; Federation for Brain Research; NS-PARK Network

Unknown

One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression? (MPI-R2*)

Parkinson's Disease

France
Stockholm University

Completed

Constructive Self Assertiveness Via the Internet (R2)

Problems With Self-assertiveness

Sweden
Masonic Cancer Center, University of Minnesota

Completed

Iron Overload in Patients Undergoing Donor Stem Cell Transplant

Cancer | Hematopoietic Stem Cell Transplantation | Allogeneic Hematopoietic Cell Transplantation

United States
Shandong Provincial Hospital

Unknown

R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

Lymphoma, B-Cell

China
Ludwig-Maximilians - University of Munich

Completed

Deflazacort in Dysferlinopathies

Dysferlinopathy | Miyoshi Myopathy | LGMD2B

Germany
Milton S. Hershey Medical Center

Completed

Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)

Parkinsonism | Parkinson's Disease (PD) | Multiple System Atrophy (MSA) | Progressive Supranuclear Palsy (PSP)

United States
The Cleveland Clinic

Completed

Rasagiline Rescue in Alzheimer's Disease Clinical Trial (R2)

Alzheimer's Disease

United States
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients (FIL_RENOIR12)

Lymphoma, Follicular

Italy
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Efficacy and Safety of Orelabrutinib Plus Lenalidomide and Rituximab (R2) Compared to Placebo Plus R2 in r/r Marginal Zone Lymphoma

Relapsed/Refractory Marginal Zone Lymphoma

China
Zhejiang University

Recruiting

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

T Lymphoblastic Leukemia/Lymphoma

China
Guangdong Provincial People's Hospital

Recruiting

A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)

Cardiovascular Diseases | Hypertension

China
First Affiliated Hospital of Zhejiang University

Recruiting

Effect of iTBS on Children With ADHD

ADHD | rTMS

China
Guangdong Provincial People's Hospital
West China Hospital; Shenzhen People's Hospital; Fifth Affiliated Hospital, Sun... and other collaborators

Recruiting

Thrombus Aspiration in STEMI Patients With High Thrombus Burden

ST-segment Elevation Myocardial Infarction (STEMI)

China
Weill Medical College of Cornell University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Columbia... and other collaborators

Recruiting

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

MRI Scans

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia (CHA)

Acute Myeloid Leukemia, Adult

China
First Affiliated Hospital of Zhejiang University

Recruiting

AI-based Multi-center Research on Identification/Classification/Aided Diagnosis of Mood Disorder

Major Depression | Bipolar Disorder Depression

China

Search clinical trials for: LGMD2B/R2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations